RCORP 2021 (Region 5 Meeting): Stimulants 2021, An Update—Clinical Issues and Treatments

Stimulant intoxication, withdrawal, and psychosis have accepted and established treatment strategies. Several lifesaving harm reduction interventions/services are available. There are no Food and Drug Administration-approved medications for treatment of stimulant use disorder, although several are promising. Behavioral treatment, especially the use of contingency management (and other approaches with supportive evidence), has by far the best evidence of effectiveness. The presenter reviewed topics of importance to clinicians treating individuals with stimulant use disorder.

1. Rick Rawson, PhD, University of Vermont Rural Center of Excellence